Dual effects of fluoxetine on mouse early embryonic development

Toxicology and Applied Pharmacology

Volumn 265, Issue 1, 2012, Pages 61-72

  Kim, Chang Woon ^a,b   Choe, Changyong ^c   Kim, Eun Jin ^a   Lee, Jae Ik ^d   Yoon, Sook Young ^e   Cho, Young Woo ^a   Han, Sunkyu ^a   Tak, Hyun Min ^a   Han, Jaehee ^a   Kang, Dawon ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c National Institute of Animal Science   (South Korea)

^d Gyeongsang National University   (South Korea)

^e CHA University   (South Korea)

Author keywords

Calcium calmodulin dependent protein kinase type 2; Fluoxetine; Pre implantation embryo development; Two pore domain K+ channel

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; FLUOXETINE; MESSENGER RNA; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; POTASSIUM CHANNEL; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLASTOCYST; CELL CULTURE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; LONG TERM EXPOSURE; LOW DRUG DOSE; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BLASTOCYST; BLOTTING, WESTERN; CALCIUM SIGNALING; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CHROMOSOMES; EMBRYONIC DEVELOPMENT; ENZYME ACTIVATION; FEMALE; FLUOXETINE; MEMBRANE POTENTIALS; MICE; OXYGEN CONSUMPTION; PATCH-CLAMP TECHNIQUES; POLYMERASE CHAIN REACTION; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; PREGNANCY; RNA, SMALL INTERFERING; SEROTONIN UPTAKE INHIBITORS; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 84867652062     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.09.020     Document Type: Article

References (61)

1. Amenta F., Vega J.A., Ricci A., Collier W.L. Localization of 5-hydroxytryptamine-like immunoreactive cells and nerve fibers in the rat female reproductive system. Anat. Rec. 1992, 233:478-484.
2. Amireault P., Dube F. Intracellular cAMP and calcium signaling by serotonin in mouse cumulus-oocyte complexes. Mol. Pharmacol. 2005, 68:1678-1687.
3. Amireault P., Dube F. Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos. Biol. Reprod. 2005, 73:358-365.
4. Bai X., Bugg G.J., Greenwood S.L., Glazier J.D., Sibley C.P., Baker P.N., Taggart M.J., Fyfe G.K. Expression of TASK and TREK, two-pore domain K+ channels, in human myometrium. Reproduction 2005, 129:525-530.
5. Bai X., Greenwood S.L., Glazier J.D., Baker P.N., Sibley C.P., Taggart M.J., Fyfe G.K. Localization of TASK and TREK, two-pore domain K+ channels, in human cytotrophoblast cells. J. Soc. Gynecol. Investig. 2005, 12:77-83.
6. Belik J. Fetal and neonatal effects of maternal drug treatment for depression. Semin. Perinatol. 2008, 32:350-354.
7. Berkeley M.B., Daussin S., Hernandez M.C., Bayer B.M. In vitro effects of cocaine, lidocaine and monoamine uptake inhibitors on lymphocyte proliferative responses. Immunopharmacol. Immunotoxicol. 1994, 16:165-178.
8. Bodis J., Bognar Z., Hartmann G., Torok A., Csaba I.F. Measurement of noradrenaline, dopamine and serotonin contents in follicular fluid of human graafian follicles after superovulation treatment. Gynecol. Obstet. Invest. 1992, 33:165-167.
9. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in pregnancy and lactation 2011.
10. Broy P., Berard A. Gestational exposure to antidepressants and the risk of spontaneous abortion: a review. Curr. Drug Deliv. 2010, 7:76-92.
11. Cammarota M., Bevilaqua L.R., Medina J.H., Izquierdo I. ERK1/2 and CaMKII-mediated events in memory formation: is 5HT regulation involved?. Behav. Brain Res. 2008, 195:120-128.
12. Chambers C.D., Johnson K.A., Dick L.M., Felix R.J., Jones K.L. Birth outcomes in pregnant women taking fluoxetine. N. Engl. J. Med. 1996, 335:1010-1015.
13. Choi J.S., Hahn S.J., Rhie D.J., Yoon S.H., Jo Y.H., Kim M.S. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J. Pharmacol. Exp. Ther. 1999, 291:1-6.
14. Cikos S., Fabian D., Makarevich A.V., Chrenek P., Koppel J. Biogenic monoamines in preimplantation development. Hum. Reprod. 2011, 26:2296-2305.
15. Dube F., Amireault P. Local serotonergic signaling in mammalian follicles, oocytes and early embryos. Life Sci. 2007, 81:1627-1637.
16. Edgar V.A., Genaro A.M., Cremaschi G., Sterin-Borda L. Fluoxetine action on murine T-lymphocyte proliferation: participation of PKC activation and calcium mobilisation. Cell. Signal. 1998, 10:721-726.
17. Edgar V.A., Sterin-Borda L., Cremaschi G.A., Genaro A.M. Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation. Eur. J. Pharmacol. 1999, 372:65-73.
18. Frick L.R., Palumbo M.L., Zappia M.P., Brocco M.A., Cremaschi G.A., Genaro A.M. Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms. Biochem. Pharmacol. 2008, 75:1817-1826.
19. Frick L.R., Rapanelli M., Cremaschi G.A., Genaro A.M. Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms. Brain Behav. Immun. 2009, 23:36-40.
20. Fumagalli F., Molteni R., Calabrese F., Frasca A., Racagni G., Riva M.A. Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J. Neurochem. 2005, 93:1551-1560.
21. Grzeskowiak L.E., Gilbert A.L., Morrison J.L. Long term impact of prenatal exposure to SSRIs on growth and body weight in childhood: evidence from animal and human studies. Reprod. Toxicol. 2012, 34:101-109.
22. Hemels M.E., Einarson A., Koren G., Lanctot K.L., Einarson T.R. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann. Pharmacother. 2005, 39:803-809.
23. Heurteaux C., Lucas G., Guy N., El Yacoubi M., Thummler S., Peng X.D., Noble F., Blondeau N., Widmann C., Borsotto M., Gobbi G., Vaugeois J.M., Debonnel G., Lazdunski M. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat. Neurosci. 2006, 9:1134-1141.
24. Honore E., Maingret F., Lazdunski M., Patel A.J. An intracellular proton sensor commands lipid- and mechano-gating of the K(+) channel TREK-1. EMBO J. 2002, 21:2968-2976.
25. Hur C.G., Choe C., Kim G.T., Cho S.K., Park J.Y., Hong S.G., Han J., Kang D. Expression and localization of two-pore domain K(+) channels in bovine germ cells. Reproduction 2009, 137:237-244.
26. Hur C.G., Kim E.J., Cho S.K., Cho Y.W., Yoon S.Y., Tak H.M., Kim C.W., Choe C., Han J., Kang D. K+ efflux through two-pore domain K+ channels is required for mouse embryonic development. Reproduction 2012, 143:625-636.
27. Il'kova G., Rehak P., Vesela J., Cikos S., Fabian D., Czikkova S., Koppel J. Serotonin localization and its functional significance during mouse preimplantation embryo development. Zygote 2004, 12:205-213.
28. Kallen B. Fluoxetine use in early pregnancy. Birth Defects Res. B Dev. Reprod. Toxicol. 2004, 71:395-396.
29. Kallen B., Olausson P.O. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol. Drug Saf. 2008, 17:801-806.
30. Kang D., Kim S.H., Hwang E.M., Kwon O.S., Yang H.Y., Kim E.S., Choi T.H., Park J.Y., Hong S.G., Han J. Expression of thermosensitive two-pore domain K+ channels in human keratinocytes cell line HaCaT cells. Exp. Dermatol. 2007, 16:1016-1022.
31. Karson C.N., Newton J.E., Livingston R., Jolly J.B., Cooper T.B., Sprigg J., Komoroski R.A. Human brain fluoxetine concentrations. J. Neuropsychiatry Clin. Neurosci. 1993, 5:322-329.
32. Kennard L.E., Chumbley J.R., Ranatunga K.M., Armstrong S.J., Veale E.L., Mathie A. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br. J. Pharmacol. 2005, 144:821-829.
33. Khozhai L.I., Puchkov V.F., Otellin V.A. The effect of a serotonin deficiency on mammalian embryonic development. Ontogenez 1995, 26:350-355.
34. Kim D. Physiology and pharmacology of two-pore domain potassium channels. Curr. Pharm. Des. 2005, 11:2717-2736.
35. Knott J.G., Gardner A.J., Madgwick S., Jones K.T., Williams C.J., Schultz R.M. Calmodulin-dependent protein kinase II triggers mouse egg activation and embryo development in the absence of Ca2+ oscillations. Dev. Biol. 2006, 296:388-395.
36. Kobayashi T., Washiyama K., Ikeda K. Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac). Br. J. Pharmacol. 2003, 138:1119-1128.
37. Kodama M., Fujioka T., Duman R.S. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol. Psychiatry 2004, 56:570-580.
38. Krishnan A., Hariharan R., Nair S.A., Pillai M.R. Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem. Pharmacol. 2008, 75:1924-1934.
39. Kusakawa S., Yamauchi J., Miyamoto Y., Sanbe A., Tanoue A. Estimation of embryotoxic effect of fluoxetine using embryonic stem cell differentiation system. Life Sci. 2008, 83:871-877.
40. Kusakawa S., Nakamura K., Miyamoto Y., Sanbe A., Torii T., Yamauchi J., Tanoue A. Fluoxetine promotes gliogenesis during neural differentiation in mouse embryonic stem cells. J. Neurosci. Res. 2010, 88:3479-3487.
41. Lee H.J., Kim J.W., Yim S.V., Kim M.J., Kim S.A., Kim Y.J., Kim C.J., Chung J.H. Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats. Mol. Psychiatry 2001, 6(610):725-728.
42. Lee A.K., Smart J.L., Rubinstein M., Low M.J., Tse A. Reciprocal regulation of TREK-1 channels by arachidonic acid and CRH in mouse corticotropes. Endocrinology 2011, 152:1901-1910.
43. Lemberger L., Rowe H., Bergstrom R.F., Farid K.Z., Enas G.G. Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanol. Clin. Pharmacol. Ther. 1985, 37:658-664.
44. Louik C., Lin A.E., Werler M.M., Hernandez-Diaz S., Mitchell A.A. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N. Engl. J. Med. 2007, 356:2675-2683.
45. Mercier G., Lennon A.M., Renouf B., Dessouroux A., Ramauge M., Courtin F., Pierre M. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J. Mol. Neurosci. 2004, 24:207-216.
46. Morrison J.L., Riggs K.W., Rurak D.W. Fluoxetine during pregnancy: impact on fetal development. Reprod. Fertil. Dev. 2005, 17:641-650.
47. Patel A.J., Lazdunski M., Honore E. Lipid and mechano-gated 2P domain K(+) channels. Curr. Opin. Cell Biol. 2001, 13:422-428.
48. Patil A.S., Kuller J.A., Rhee E.H. Antidepressants in pregnancy: a review of commonly prescribed medications. Obstet. Gynecol. Surv. 2011, 66:777-787.
49. Pato M.T., Murphy D.L., DeVane C.L. Sustained plasma concentrations of fluoxetine and/or norfluoxetine four and eight weeks after fluoxetine discontinuation. J. Clin. Psychopharmacol. 1991, 11:224-225.
50. Pellegrino T.C., Bayer B.M. Modulation of immune cell function following fluoxetine administration in rats. Pharmacol. Biochem. Behav. 1998, 59:151-157.
51. Pellegrino T.C., Bayer B.M. Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity. Brain Behav. Immun. 2002, 16:87-103.
52. Rahimi R., Nikfar S., Abdollahi M. Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials. Reprod. Toxicol. 2006, 22:571-575.
53. Reeve H.L., Nelson D.P., Archer S.L., Weir E.K. Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology. Am. J. Physiol. 1999, 276:L213-L219.
54. Thummler S., Duprat F., Lazdunski M. Antipsychotics inhibit TREK but not TRAAK channels. Biochem. Biophys. Res. Commun. 2007, 354:284-289.
55. Trimarchi J.R., Liu L., Smith P.J., Keefe D.L. Apoptosis recruits two-pore domain potassium channels used for homeostatic volume regulation. Am. J. Physiol. Cell Physiol. 2002, 282:C588-C594.
56. Tsao C.W., Lin C.F., Wu H.T., Ma C.T., Huang W.C., Hsieh C.Y., Choi P.C., Young K.C. Glycogen synthase kinase-3beta is critical for interferon-alpha-induced serotonin uptake in human Jurkat T cells. J. Cell. Physiol. 2011, 227:2556-2566.
57. Vesela J., Rehak P., Mihalik J., Czikkova S., Pokorny J., Koppel J. Expression of serotonin receptors in mouse oocytes and preimplantation embryos. Physiol. Res. 2003, 52:223-228.
58. Walsh K.B., Parks G.E. Changes in cardiac myocyte morphology alter the properties of voltage-gated ion channels. Cardiovasc. Res. 2002, 55:64-75.
59. Wogelius P., Norgaard M., Gislum M., Pedersen L., Munk E., Mortensen P.B., Lipworth L., Sorensen H.T. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 2006, 17:701-704.
60. Wu H., Smyth J., Luzzi V., Fukami K., Takenawa T., Black S.L., Allbritton N.L., Fissore R.A. Sperm factor induces intracellular free calcium oscillations by stimulating the phosphoinositide pathway. Biol. Reprod. 2001, 64:1338-1349.
61. Yoshizawa M., Nakamoto S., Tsunoda Y., Muramatsu T. A short-term hypotonic treatment for chromosome preparation of intact and zona-penetrated mouse embryos. Theriogenology 1990, 33:789-797.